ORPH Stock: Is There a Big Orphazyme Catalyst on June 17?

investorplace2021-06-11

Today, Orphazyme(NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing. This is a stock that closed yesterday trading at $5.22. At the time of ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

OMTTrading
2021-06-17
OMTTrading
How did he know there was going to be a pump on the 17th?
BeBob
2021-06-11
BeBob
Like thanks
Boliao
2021-06-11
Boliao
Like and comment pls
- dawnyong:
  Yes
- BeBob:
  Like thanks
Fredwkh
2021-06-11
Fredwkh
Like I
- Boliao:
  Reply pls
Ahleepapa
2021-06-11
Ahleepapa
BUY!!!
- Glenna:
  yeah
Ken3888
2021-06-11
Ken3888
Well noted

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1141539721?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-11 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141539721","market":"us","top_or_hot":-1,"title":"ORPH Stock: Is There a Big Orphazyme Catalyst on June 17?","media":"investorplace","content":"<div>\n<p>Today, Orphazyme(NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing.\nThis is a stock that closed yesterday trading at $5.22. At the time of ...</p>\n\n<a href=\"https://investorplace.com/2021/06/orph-stock-is-there-a-big-orphazyme-catalyst-on-june-17/\">网页链接</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ORPH Stock: Is There a Big Orphazyme Catalyst on June 17?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nORPH Stock: Is There a Big Orphazyme Catalyst on June 17?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 07:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/orph-stock-is-there-a-big-orphazyme-catalyst-on-june-17/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today, Orphazyme(NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing.\nThis is a stock that closed yesterday trading at $5.22. At the time of ...</p>\n\n<a href=\"https://investorplace.com/2021/06/orph-stock-is-there-a-big-orphazyme-catalyst-on-june-17/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://investorplace.com/2021/06/orph-stock-is-there-a-big-orphazyme-catalyst-on-june-17/","article_id":"1141539721","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141539721","pubTimestamp":1623367933,"columns":[],"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Today, Orphazyme(NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"奥菲股票：6月17日有没有大奥菲催化？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORPH":0.9},"content_text":"Today, Orphazyme(NASDAQ:ORPH) is a big mover. And by big mover, I mean ORPH stock is up nearly 1,000% at the time of writing.\nThis is a stock that closed yesterday trading at $5.22. At the time of writing, shares of ORPH stock are trading in excess of $56.\nObviously, something is cooking with this stock right now. And investors seem to be asking what the heck is going on. A series of halts this morning, and immediate pops following the halts, have triggeredspeculationsome sort of manipulation is occurring.\nIn the absence of any real news, let’s take a look at what this company does, and what sort of catalysts investors (might) be banking on with this stock.\nWhat Is Orphazyme Stock All About?\n\nOrphazymeis a late-stage biopharma company specializing in pioneering a heat-shock protein response for the treatment of neurodegenerative orphan diseases.\nAccordingly, the company aims to harness the amplification of heat-shock proteins to develop and commercialize novel therapeutics.\nThe company’s leading drug candidate is arimoclomol.\nThis drug is in clinical development targeted at four orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), Inclusion Body Myositis (IBM) and Gaucher disease.\nOrphazyme is based out of Denmark, and its shares are listed in the U.S. on theNasdaqas an American Depositary Receipt.\nThis company’s operations mainly focus in Europe, but it also has operations in the United States.\nOrphazyme stock briefly touched anall-time highof $77.77 today, giving this company a market cap of $2.7 billion at its peak.\n\nORPH Stock Soaring on Little News\nDespite today’s move on what appears to be no real catalysts, there are some noteworthy items for investors to consider with ORPH stock.\nThe main catalyst investors appear to have their radar is anFDA extended review periodfor the company’s arimoclomol treatment, which expires June 17. Investors have taken to social media to chatabout the PDUFA date as a binary event. This price action could be an indication some good news is on the horizon. However, in the absence of any publicly available information, investors need to be extremely cautious.\nThe company’s arimoclomol drug is aimed at the treatment of Niemann-Pick Disease Type C (NPC). This is a rare disease, and the drug remains under the priority review designation by the FDA. Indeed, if some positive news arises to warrant this rise, investors may wonder how this stock rose so quickly ahead of the news.\nFor now, investors are left scratching their heads with this one. This is a stock I’ve added to my watch list, and I suggest investors do the same. It will be an intriguing one to watch.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":163147465,"gmtCreate":1623864968957,"gmtModify":1623864968957,"author":{"id":"3585177463615228","authorId":"3585177463615228","name":"OMTTrading","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585177463615228","authorIdStr":"3585177463615228"},"htmlText":"How did he know there was going to be a pump on the 17th?","listText":"How did he know there was going to be a pump on the 17th?","text":"How did he know there was going to be a pump on the 17th?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163147465","repostId":1141539721,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181921279,"gmtCreate":1623371172991,"gmtModify":1634034123530,"author":{"id":"3585307651801295","authorId":"3585307651801295","name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585307651801295","authorIdStr":"3585307651801295"},"htmlText":"Like thanks","listText":"Like thanks","text":"Like thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181921279","repostId":1141539721,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":181968193,"gmtCreate":1623370857012,"gmtModify":1634034131865,"author":{"id":"3577867707758098","authorId":"3577867707758098","name":"Boliao","avatar":"https://static.tigerbbs.com/1f0231a16b84d9b4acb177deb78d02ba","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3577867707758098","authorIdStr":"3577867707758098"},"htmlText":"Like and comment pls&nbsp;","listText":"Like and comment pls&nbsp;","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/181968193","repostId":1141539721,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4674958,"gmtCreate":1623370921164,"gmtModify":1635328641424,"authorId":3568205918507543,"author":{"id":3568205918507543,"idStr":"3568205918507543","authorId":3568205918507543,"name":"dawnyong","avatar":"https://static.tigerbbs.com/4dc32f94211c2b67550a75832319e35a","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181968193,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"},{"id":4675125,"gmtCreate":1623371269690,"gmtModify":1635328623411,"authorId":3585307651801295,"author":{"id":3585307651801295,"idStr":"3585307651801295","authorId":3585307651801295,"name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181968193,"type":1,"supId":0,"prevId":0,"content":"Like thanks","text":"Like thanks","html":"Like thanks"}],"langContent":"EN"},{"id":181935428,"gmtCreate":1623370024764,"gmtModify":1634034156120,"author":{"id":"3570424148942091","authorId":"3570424148942091","name":"Fredwkh","avatar":"https://static.tigerbbs.com/301d103aff8ff9955978aa630ee85588","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3570424148942091","authorIdStr":"3570424148942091"},"htmlText":"Like I&nbsp;","listText":"Like I&nbsp;","text":"Like I","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181935428","repostId":1141539721,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4674929,"gmtCreate":1623370846263,"gmtModify":1635328644501,"authorId":3577867707758098,"author":{"id":3577867707758098,"idStr":"3577867707758098","authorId":3577867707758098,"name":"Boliao","avatar":"https://static.tigerbbs.com/1f0231a16b84d9b4acb177deb78d02ba","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181935428,"type":1,"supId":0,"prevId":0,"content":"Reply pls ","text":"Reply pls ","html":"Reply pls "}],"langContent":"EN"},{"id":181936349,"gmtCreate":1623369981581,"gmtModify":1634034158793,"author":{"id":"3585038405943602","authorId":"3585038405943602","name":"Ahleepapa","avatar":"https://static.tigerbbs.com/dcc1fea9c38112b58c68a2d96017330b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3585038405943602","authorIdStr":"3585038405943602"},"htmlText":"BUY!!!","listText":"BUY!!!","text":"BUY!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/181936349","repostId":1141539721,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4674577,"gmtCreate":1623370053490,"gmtModify":1635328683349,"authorId":3570769377369254,"author":{"id":3570769377369254,"idStr":"3570769377369254","authorId":3570769377369254,"name":"Glenna","avatar":"https://static.tigerbbs.com/8cb1540811be40c4d05341502c35498c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":181936349,"type":1,"supId":0,"prevId":0,"content":"yeah","text":"yeah","html":"yeah"}],"langContent":"EN"},{"id":181993168,"gmtCreate":1623369614254,"gmtModify":1634034170712,"author":{"id":"3581507312795318","authorId":"3581507312795318","name":"Ken3888","avatar":"https://static.tigerbbs.com/493a96d6ecc5aa191181e04cc37afca5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581507312795318","authorIdStr":"3581507312795318"},"htmlText":"Well noted","listText":"Well noted","text":"Well noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181993168","repostId":1141539721,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":92,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141539721"}